CJC-1295 with DAC – Research Grade Peptide (5 mg)
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic
research-grade peptide supplied for use exclusively in controlled
laboratory and in-vitro research environments. This formulation incorporates
a Drug Affinity Complex (DAC), which chemically distinguishes it from
non-DAC CJC-1295 variants.
In experimental research settings, CJC-1295 with DAC is examined in
non-clinical models focusing on peptide-receptor interaction, molecular
signaling behavior, and peptide stability under extended binding conditions.
Its modified structure makes it suitable for laboratory systems designed
to study peptide persistence and interaction dynamics in controlled
scientific environments.
This compound is supplied exclusively for laboratory research, analytical
testing, and in-vitro scientific investigation. It is not intended for
human or animal use and is not approved for therapeutic, diagnostic,
cosmetic, or medical applications.
For research use only. Not for human or animal consumption.
Chemical & Peptide Information
| Peptide Name | CJC-1295 with DAC |
| Peptide Type | Synthetic GHRH Analog with Drug Affinity Complex |
| Peptide Length | ~30 Amino Acids (DAC-Modified) |
| Molecular Weight | ~3,640 Da |
| Modification | Drug Affinity Complex (DAC) |
| Content | 5 mg per vial |
| Form | Lyophilized Powder (Research-Grade) |
Important Notice: CJC-1295 with DAC is chemically and
functionally distinct from CJC-1295 (No DAC). Researchers should
verify experimental requirements and formulation specifications prior
to use.
Research Overview
In experimental and preclinical research contexts, CJC-1295 with DAC is
investigated in laboratory systems examining peptide-mediated signaling,
receptor interaction models, and molecular stability behavior. All studies
are conducted exclusively in non-clinical, in-vitro research environments.
Key Research Focus Areas
- Peptide-receptor interaction research
- Molecular signaling pathway investigation
- Peptide stability and binding persistence studies
- Experimental peptide interaction models
- In-vitro biochemical pathway analysis
All information associated with CJC-1295 with DAC is derived from
experimental and preclinical research contexts only. No claims are made
regarding medical, therapeutic, cosmetic, or clinical outcomes.
Reviews
There are no reviews yet.